Dr. Michael Bender

powered by
COS Expertise®
University of Washington
School of Medicine
Pediatric Oncology
Assistant Professor
Fred Hutchinson Cancer Research Center
Clinical Research Division
Pediatric Oncology

Mailing Address

1100 Fairview Avenue North, A3-025
Seattle, Washington 98109
United States

Contact Information

Qualifications

M.D., University of Washington, 1990.
Ph.D., University of Washington, Pathology, 1989.

Expertise and Research Interests

Models for tissue specific gene activation propose a multi-step process in which a locus is re-localized from areas of silenced heterochromatin to ˇ§activeˇ¨ centers where a nuclease sensitive ˇ§openˇ¨ conformation is assumed, and chromatin remodeling and epigenetic modifications such as histone hyper-acetylation occur. Once this state is achieved, long-range enhancers and promoter proximal sequences lead to full gene activation. Locus control regions (LCRs) are sequence elements originally thought to lead to high-level position independent expression of linked genes in transgenic mice.
To address the role of LCRs and other distal regulatory elements I have been studying the murine bƒ{globin locus during erythroid maturation, a process that is characterized by profound chromatin condensation and silencing of all but a few genes. The bƒ{globin LCR is comprised of six DNaseI hypersensitive sites (HSs) located far upstream of the bƒ{like globin genes. Transgenic experiments and the analysis of a human bƒ{globin locus carrying a naturally occurring deletion the LCR and 27kb upstream (Hispanic thalassemia) had led to the notion that the LCR was responsible for an activated state of the locus defined by an ˇ§openˇ¨ active chromatin structure, localization away from peri-centromeric heterochromatin (PCH), generalized histone hyper-acetylation, and high-level b-globin transcription. The focus of my research is understanding how this ˇ§openˇ¨ activated state of the bƒ{globin locus is established and maintained during erythroid maturation. My initial attempts to address this involved deletion of the endogenous murine LCR by homologous recombination. Surprisingly, while a dramatic reduction in expression of the b-like globin genes was observed, the deletion resulted in no chromatin phenotype (no measurable effect on nuclease sensitivity, promoter hypersensitive site formation or core histone hyper-acetylation) or alteration in nuclear location of the locus. These results raise several major questions which are the focus of my research including: 1) which non-LCR sequences are capable of establishing an open bƒ{globin chromatin domain in this generally repressive environment, 2) what epigenetic modifications are associated with the transition from ˇ§openˇ¨ to ˇ§closedˇ¨ chromatin, 3) how do these elements affect the state of the open domain and transcription during erythroid maturation and 4) what is the mechanism by which the LCR activates gene expression.

Keywords

COS Keywords:

Oncology, Pathology, Pediatrics.

Additional Terms:

Oncology.

Publications

  • Bender MA, Roach JN, Halow J, Close J, Alami R, Bouhassira EE, Groudine M, Fiering SN, Targeted deletion of 5'HS1 and 5'HS4 of the beta-globin locus control region reveals additive activity of the DNaseI hypersensitive sites, Blood, 98(7), 2022-7, October 2001 Abstract
  • Bender MA, Mehaffey MG, Telling A, Hug B, Ley TJ, Groudine M, Fiering S, Independent formation of DnaseI hypersensitive sites in the murine beta-globin locus control region, Blood, 95(11), 3600-4, June 2000 Abstract
  • Bender MA, Bulger M, Close J, Groudine M, Beta-globin gene switching and DNase I sensitivity of the endogenous beta-globin locus in mice do not require the locus control region, Molecular Cell, 5(2), 387-93, February 2000 Abstract
  • Alami R, Bender MA, Feng YQ, Fiering SN, Hug BA, Ley TJ, Groudine M, Bouhassira EE, Deletions within the mouse beta-globin locus control region preferentially reduce beta(min) globin gene expression, Genomics, 63(3), 417-24, February 2000 Abstract
  • Bulger M, van Doorninck JH, Saitoh N, Telling A, Farrell C, Bender MA, Felsenfeld G, Axel R, Groudine M, von Doorninck JH, Conservation of sequence and structure flanking the mouse and human beta-globin loci: the beta-globin genes are embedded within an array of odorant receptor genes, Proceedings of the National Academy of Sciences (USA), 96(9), 5129-34, April 1999 Abstract
  • Bender MA, Reik A, Close J, Telling A, Epner E, Fiering S, Hardison R, Groudine M, Description and targeted deletion of 5' hypersensitive site 5 and 6 of the mouse beta-globin locus control region, Blood, 92(11), 4394-403, December 1998 Abstract
  • Epner E, Reik A, Cimbora D, Telling A, Bender MA, Fiering S, Enver T, Martin DI, Kennedy M, Keller G, Groudine M, The beta-globin LCR is not necessary for an open chromatin structure or developmentally regulated transcription of the native mouse beta-globin locus, Molecular Cell, 2(4), 447-55, October 1998 Abstract

Profile Details

Last Updated: 1/13/2003

COS Expertise ID #345981
Reference this profile directly: http://myprofile.cos.com/MBender5